Bridging the gaps in detection of structural cardiotoxicity in stem cell-derived cardiomyocytes: promise of miR-133b, miR-184 and miR-208b-3p.
弥合干细胞衍生心肌细胞结构性心脏毒性检测方面的差距：miR-133b、miR-184 和 miR-208b-3p 的前景
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1584734
Cherubin M, Delaunois A, Valentin J P, Alaerts M, Guns P J, Gryshkova V
